NCT06127810View on ClinicalTrials.gov

MRI Gadopiclenol Enhanced Imaging of CNS Tumors

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

December 30, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Image
Interventions
DEVICE

CE MRI on 0.064T Scanner

Pt will undergo contrast enhanced images using Gadopiclenol on Hyperfine MRI

DRUG

Gadopiclenol

Subjects will receive Gadopiclenol instead of standard of care contrast

Sponsors

Collaborators (1)

Guerbet
All Listed Sponsors
collaborator

Guerbet

INDUSTRY

lead

Medical University of South Carolina

OTHER